STAT Plus: Novo Nordisk offers programs to lower insulin costs as pressure over pricing mounts
The two-pronged effort involves a $99 cash card for a month's supply and the introduction of authorized generic versions of two different insulin products.
No hay comentarios:
Publicar un comentario